Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42)

Jurisdiction:
Federal
Incentive Type:Grant Program
Industries:
Medical
Eligible Sector:
Business
Category:
Financial Incentive
Time Period:
FY 2015
Governing Body:National Institutes of Health
What’s it worth?:Not mentioned

Administered by The National Institute of Mental Health (NIMH) of The National Institutes of Health (NIH). It is a Small Business Innovation Technology Transfer Research (STTR) grant opportunity (PA-14-196) for small business concerns (SBCs) — with no more than 500 employees — to develop technologies to advance translational, clinical, and neuroscience research on mental disorders; and to promote evidence-based mental health care.

Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) or even higher if the additional funding is determined to be justified or necessary.